Health news
Having an immune-mediated disease may increase a person’s risk of developing cancer, according to a large study published in JAMA Oncology. Researchers identified immune-mediated diseases associated with an elevated risk of cancer in the involved…
Secura Bio has voluntarily withdrawn the indication for Copiktra® (duvelisib) for the treatment of adults with relapsed or refractory follicular lymphoma after at least 2 prior systemic therapies. In September 2018, Copiktra, an oral inhibitor…
The Food and Drug Administration (FDA) has approved Rituxan (rituximab) in combination with chemotherapy for the treatment of patients 6 months of age and older with previously untreated, advanced stage, CD20-positive, diffuse large B-cell lymphoma…
COVID-19 mortality has improved over the course of the pandemic for European patients with cancer, according to a study published in JAMA Oncology. The 14-day case fatality rate decreased from 29.8% during February-March 2020 to…
Patients with lymphoproliferative cancers may have a higher risk of breakthrough COVID-19 than patients with myeloproliferative cancers, according to research published in Blood. Researchers identified patients with hematologic malignancies who developed COVID-19 after full or…
The Food and Drug Administration (FDA) has accepted for review the New Drug Application for parsaclisib for the treatment of patients with relapsed or refractory follicular lymphoma (FL), marginal zone lymphoma (MZL) and mantle cell…
An international survey has revealed barriers to accessing cancer drugs deemed essential for routine clinical care. The survey was published in The Lancet Oncology. Researchers surveyed medical oncologists from 82 countries and found that some…
A study of more than 300,000 patients with COVID-19 and a history of cancer provides insights that can inform clinical care and etiologic studies, according to researchers. The group reported findings from this study in…
Global registry data suggest that children with cancer have a higher risk of severe illness and death from COVID-19 when compared with the general pediatric population.1 Prior data from small cohorts indicated that pediatric cancer…
Patients with lymphoma may experience a continued decline in cognitive function 6 months after receiving chemotherapy, according to a study published in the Journal of the National Cancer Institute.1 The study showed no differences in…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021